FDA Advances Work On Chemical-Hazard Early-Detection Program
This article was originally published in The Rose Sheet
Executive Summary
In a recent contract solicitation announcement, FDA’s Center for Food Safety and Applied Nutrition offers insight into its developing “early warning” system for potential chemical hazards in cosmetics, dietary supplements and foods. The agency seeks a contractor with expertise to mine data and identify potential risks based on hazard “signals” across a spectrum of information sources.
You may also be interested in...
FDA Identifies Need For Updated Chemical-Evaluation Processes In CFSAN
FDA says it will look to update processes across CFSAN divisions, including its cosmetics office, for assessing and sharing information related to chemical hazards, following completion of a review that included interviews with current and former FDAers and consultation with outside experts. In its report, CFSAN prioritizes an in silico system that would house chemical-risk-assessment data and use predictive tools to provide centers with safety signals related to substances used in cosmetics, dietary supplements and other regulated products.
FDA Identifies Need For Updated Chemical-Evaluation Processes In CFSAN
FDA says it will look to update processes across CFSAN divisions, including its cosmetics office, for assessing and sharing information related to chemical hazards, following completion of a review that included interviews with current and former FDAers and consultation with outside experts. In its report, CFSAN prioritizes an in silico system that would house chemical-risk-assessment data and use predictive tools to provide centers with safety signals related to substances used in cosmetics, dietary supplements and other regulated products.
FDA Identifies Need For Updated Chemical-Evaluation Processes In CFSAN
FDA says it will look to update processes across CFSAN divisions, including its cosmetics office, for assessing and sharing information related to chemical hazards, following completion of a review that included interviews with current and former FDAers and consultation with outside experts. In its report, CFSAN prioritizes an in silico system that would house chemical-risk-assessment data and use predictive tools to provide centers with safety signals related to substances used in cosmetics, dietary supplements and other regulated products.